BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation has agreed to invest up to $15 million in ReCode Therapeutics to support their gene editing collaboration with Intellia Therapeutics. The ...

BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation is investing up to $9 million in additional funds in Arcturus Therapeutics to test an inhaled messenger RNA (mRNA) therapy that could ...

The Cystic Fibrosis Foundation San Diego Guild Luncheon was held May 9 at the Santaluz Club. The event brought together community leaders, philanthropists, and supporters to raise awareness and funds ...

The Cystic Fibrosis Foundation said today it will spend up to $58 million over six years to expand its drug development with Pfizer to hasten development of drugs for the most common mutation ...

Prime Medicine secures up to $24 million from the CF Foundation to advance Prime Editors for cystic fibrosis treatment. Prime Medicine, Inc. has announced an agreement with the Cystic Fibrosis ...